LAG-3 and GAL-3 in Endometrial Carcinoma: Emerging Candidates for Immunotherapy
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Gynecological Pathology"
DOI: 10.1097/pgp.0000000000000608
Abstract: LAG-3 is an immunosuppressive checkpoint molecule expressed on T cells. One of its ligands, GAL-3, can promote the progression of malignancy and has been identified on tumor cells. Both LAG-3 and GAL-3 are the targets… read more here.
Keywords: mismatch repair; repair deficient; lag gal; repair ... See more keywords